Evidence map›Paper›PMID 39043703›Full record

ArticleNature communications2024

Membrane remodeling by FAM92A1 during brain development regulates neuronal morphology, synaptic function, and cognition.

Liang Wang, Ziyun Yang, Fudo Satoshi, Xavier Prasanna, Ziyi Yan, Helena Vihinen, Yaxing Chen, Yue Zhao, Xiumei He, Qian Bu and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Liang Wang *Mental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Ziyun Yang *Mental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Fudo SatoshiHelsinki Institute of Life Science - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-9925-5131
Xavier PrasannaDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-2270-5493
Ziyi YanFaculty of Biological and Environmental Sciences, University of Helsinki, 00014, Helsinki, Finland.
Helena VihinenHelsinki Institute of Life Science (HiLIFE) - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-3862-9237
Yaxing ChenMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yue ZhaoMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Xiumei HeMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Qian BuMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Hongchun LiMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Ying ZhaoMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Linhong JiangMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Feng QinMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yanping DaiMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Ni ZhangMental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Meng QinMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.
Weihong KuangMental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Yinglan ZhaoMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China.ORCID 0000-0002-5168-5842
Eija JokitaloHelsinki Institute of Life Science (HiLIFE) - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4159-6934
Ilpo VattulainenDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7408-3214
Tommi KajanderHelsinki Institute of Life Science - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-5094-227X
Hongxia ZhaoFaculty of Biological and Environmental Sciences, University of Helsinki, 00014, Helsinki, Finland. hongxia.zhao@helsinki.fi.ORCID 0000-0002-1606-5621
Xiaobo CenMental Health Center and National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, 610041, China. xbcen@scu.edu.cn.ORCID 0000-0002-9760-5238

Funding

Academy of Finland (Suomen Akatemia) 323670Academy of Finland (Suomen Akatemia) 331349Academy of Finland (Suomen Akatemia) 336234Academy of Finland (Suomen Akatemia) 346135China Postdoctoral Science Foundation 2021M702362Department of Science and Technology of Sichuan Province (Sichuan Provincial Department of Science and Technology) 23NSFSC2884Human Frontier Science Program (HFSP) RGP0059/2019National Natural Science Foundation of China (National Science Foundation of China) 32000719National Natural Science Foundation of China (National Science Foundation of China) 81272459National Natural Science Foundation of China (National Science Foundation of China) 81871043National Natural Science Foundation of China (National Science Foundation of China) 82071494National Natural Science Foundation of China (National Science Foundation of China) 82371498
6 · The paper itself

Abstract

The Bin/Amphiphysin/Rvs (BAR) domain protein FAM92A1 is a multifunctional protein engaged in regulating mitochondrial ultrastructure and ciliogenesis, but its physiological role in the brain remains unclear. Here, we show that FAM92A1 is expressed in neurons starting from embryonic development. FAM92A1 knockout in mice results in altered brain morphology and age-associated cognitive deficits, potentially due to neuronal degeneration and disrupted synaptic plasticity. Specifically, FAM92A1 deficiency impairs diverse neuronal membrane morphology, including the mitochondrial inner membrane, myelin sheath, and synapses, indicating its roles in membrane remodeling and maintenance. By determining the crystal structure of the FAM92A1 BAR domain, combined with atomistic molecular dynamics simulations, we uncover that FAM92A1 interacts with phosphoinositide- and cardiolipin-containing membranes to induce lipid-clustering and membrane curvature. Altogether, these findings reveal the physiological role of FAM92A1 in the brain, highlighting its impact on synaptic plasticity and neural function through the regulation of membrane remodeling and endocytic processes.

Indexed as

BrainCell MembraneCognitionIntracellular Signaling Peptides and ProteinsMitochondrial ProteinsProteinsSynapsesAnimalsCell ShapeCognition DisordersEndocytosisFemaleMaleMice, Inbred C57BLMice, KnockoutNeurodegenerative DiseasesCibar1 protein, mouseIntracellular Signaling Peptides and ProteinsMitochondrial ProteinsProteins

Identifiers

PMID39043703
PMCPMC11266426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.